REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $28,939,000 | +35.5% | 1,398,009 | +6.1% | 0.01% | +25.0% |
| Q3 2016 | $21,360,000 | +31.5% | 1,317,731 | +10.3% | 0.00% | 0.0% |
| Q2 2016 | $16,243,000 | -19.1% | 1,194,355 | +3.8% | 0.00% | -20.0% |
| Q1 2016 | $20,088,000 | -44.0% | 1,150,499 | +9.6% | 0.01% | -37.5% |
| Q4 2015 | $35,859,000 | +60.0% | 1,049,725 | +39.4% | 0.01% | +33.3% |
| Q3 2015 | $22,408,000 | -2.8% | 752,964 | +4.4% | 0.01% | 0.0% |
| Q2 2015 | $23,058,000 | +105.3% | 720,999 | +33.1% | 0.01% | +100.0% |
| Q1 2015 | $11,230,000 | +28.6% | 541,727 | +5.1% | 0.00% | +50.0% |
| Q4 2014 | $8,734,000 | +124.1% | 515,592 | +155.7% | 0.00% | +100.0% |
| Q3 2014 | $3,898,000 | -35.0% | 201,636 | +14.4% | 0.00% | -50.0% |
| Q2 2014 | $5,995,000 | +0.3% | 176,314 | -7.1% | 0.00% | 0.0% |
| Q1 2014 | $5,977,000 | – | 189,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |